[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.191.72. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 9, 2005

Blood Transfusion in Patients With Acute Coronary Syndrome—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;293(6):673-674. doi:10.1001/jama.293.6.673-b

In Reply: Mr Rathore and Drs Radford and Krumholz express concern about our conclusions, which differ from those of their study.1 While both studies find that transfusion for a hematocrit value of 36% or more is associated with increased mortality, their study suggests that transfusion for a hematocrit below 30% is associated with decreased mortality. We could not identify a hematocrit threshold below which transfusion was beneficial, but we found that transfusion for a hematocrit greater than 25% was associated with harm. Therefore, the issue is not whether blood transfusion is harmful but the inflection point at which it is associated with harm. Of the 2 studies they cite in support of liberal transfusion, one is an observational study that found a benefit of transfusion only in an unadjusted analysis of 202 patients with a “cardiovascular diagnosis” and an Acute Physiology and Chronic Health Evaluation score of more than 20,2 and the other is a subgroup analysis of a randomized trial that included only 77 patients with unstable angina or myocardial infarction.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×